Answer
Capsules are licensed for children aged 10 to 16 years with chronic kidney disease stages 3 or 4. The selected injection is licensed only for adults.
Sources for this answer
- Zemplar Soft Capsules 2 mcg — Current selected SmPCemc · Summary of Product Characteristics
- Zemplar 5 microgram/ml Solution for Injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.